Why Not Sequence the Whole Genome?
Add bookmark
Professor René Bernards, Head of the Division/Group Leader, Molecular Carcinogenesis at The Netherlands Cancer Institute, joins Andrea Charles from Pharma IQ, to discuss current trends in next-generation DNA sequencing in oncology research, industry uptake of next-generation DNA sequencing technologies, the advantages of enriching and true commercial potential of personalised medicine. [inlinead] Have Your Say Rate this feature and give us your feedback in the comments section below
